Clark Kenneth A 4
4 · Summit Therapeutics Inc. · Filed Oct 12, 2021
Insider Transaction Report
Form 4
Clark Kenneth A
Director
Transactions
- Award
Stock Option (right to buy)
2021-10-07+200,000→ 200,000 totalExercise: $5.03Exp: 2031-10-07→ Common Stock (200,000 underlying) - Award
Stock Option (right to buy)
2021-10-07+6,250→ 206,250 totalExercise: $5.03Exp: 2031-10-07→ Common Stock (6,250 underlying)
Footnotes (3)
- [F1]The option was granted on October 7, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on October 7, 2022.
- [F2]The option was granted on October 7, 2021 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days this year the reporting person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2021.
- [F3]Not applicable.